Background
A report published by Azoth Analytics highlights different factors and opportunities prevailing in the oGlobal Acute Respiratory Distress Syndrome Market (2024 Edition)o. According to the report, Global Acute Respiratory Distress Syndrome Market was valued at USD 356.66 Million and is expected to grow at a CAGR of 8.7% during 2025-2030.
The report explores a multi-faceted opportunity landscape in terms of market segmentation by End-User (Hospitals, Ambulatory Surgical Centers, Academic and Research Institutions, Specialty Clinics and Other End-Users), By Mode of Administration (Intravenous, Inhalation, Topical and Oral) and By Treatment Mode (Drugs and Devices)
Market Overview
The Acute Respiratory Distress Syndrome (ARDS) market has seen significant growth due to the rising incidence of ARDS, advancements in diagnostic and therapeutic technologies, and increasing awareness of critical care management. ARDS is a severe lung condition caused by various factors, including infections, trauma, and inhalation injuries, leading to respiratory failure. The market is driven by the need for effective treatments and management strategies to improve patient outcomes.
The COVID-19 pandemic has notably impacted the ARDS market, as severe COVID-19 cases often develop ARDS, increasing the demand for critical care treatments. The pandemic has heightened awareness of respiratory diseases and the importance of advanced healthcare infrastructure.
Advancements in medical technology, such as extracorporeal membrane oxygenation (ECMO) and non-invasive ventilation (NIV), have enhanced ARDS treatment. These technologies, along with pharmaceutical interventions like corticosteroids and antibiotics, are crucial in managing ARDS symptoms and complications.
Geographical Insights
Americas represent the largest market for ARDS treatments, driven by advanced healthcare infrastructure, significant R&D activities, and a high prevalence of respiratory diseases. The United States is a key market, with extensive use of advanced therapies and a high incidence of ARDS cases.
In the Americas, the market benefits from a mature healthcare system, the presence of leading pharmaceutical and medical device companies, and a strong focus on critical care management. The impact of the COVID-19 pandemic has further emphasized the importance of ARDS treatment capabilities.
The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising incidence of respiratory diseases, and growing awareness of critical care management. Countries like China, Japan, and India are key markets, with expanding healthcare infrastructure and a focus on improving patient outcomes.
In Europe, the market for ARDS treatments is driven by strong healthcare systems, high patient awareness, and ongoing research efforts. Countries like Germany, France, and the UK are significant contributors, with a focus on developing new therapies and improving critical care practices.
Market Segmentation
By End-User:
• Hospitals
• Ambulatory Surgical Centers
• Academic and Research Institutions
• Specialty Clinics
• Other End-Users
By Mode of Administration:
• Intravenous
• Inhalation
• Topical
• Oral
By Treatment Mode:
• Drugs
• Devices
By Geography
• Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
• Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
• Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)
Key Companies
The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Acute Respiratory Distress Syndrome Market include:
• United Therapeutics
• Athersys
• GE Healthcare
• Apeptico Forschung
• Fisher & Paykel Healthcare Limited
• NRx Pharmaceuticals, Inc.
• HEALIOS K.K
• BioMarck Pharmaceuticals
• Hamilton Company
• Faron Pharmaceuticals
Reasons to buy this report:
• In-Depth Comparative Assessment of Top 20 Markets in the Acute Respiratory Distress Syndrome Market: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
• Comprehensive Historical, Present, and Future Analytics of the Acute Respiratory Distress Syndrome Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Acute Respiratory Distress Syndrome Market.
• Detailed Analysis of Acute Respiratory Distress Syndrome Market By End-User, Mode of Administration, and Treatment Mode Across 20 Countries
• Beyond the Purchase: 90 Days of Support
o Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
o Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
o Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
• Strategic Company Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.
Table of Contents 1. Market Background 1.1 Scope and Product Outlook 1.2 Executive Summary 1.3 Research Methodology 2. Analyst Recommendations 3. Global Acute Respiratory Distress Syndrome Market: Historic and Forecast 3.1 Impact Analysis of Macro Economic Factors on Global Acute Respiratory Distress Syndrome Market 3.2 Acute Respiratory Distress Syndrome Market Type Matrix 3.3 Global Acute Respiratory Distress Syndrome Market: Dashboard 3.4 Global Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR) 3.5 Global Acute Respiratory Distress Syndrome Market: Market Value Assessment 3.6 Assessment Degree of Impact of COVID-19 on Global Acute Respiratory Distress Syndrome Market 3.7 Global Acute Respiratory Distress Syndrome Market Segmentation: By End-User 3.7.1 Global Acute Respiratory Distress Syndrome Market, By End-User Overview 3.7.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By End-User (2025-2030) 3.7.3 Global Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR) 3.7.4 Global Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR) 3.7.5 Global Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR) 3.7.6 Global Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR) 3.7.7 Global Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR) 3.8 Global Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration 3.8.1 Global Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview 3.8.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By Mode of Administration (2025-2030) 3.8.3 Global Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 3.8.4 Global Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR) 3.8.5 Global Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR) 3.8.6 Global Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 3.9 Global Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode 3.9.1 Global Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview 3.9.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By Treatment Mode (2025-2030) 3.9.3 Global Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR) 3.9.4 Global Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR) 4. Acute Respiratory Distress Syndrome Market, Region Analysis 4.1 Regional Coverage of the Study 4.2 Regional Snapshot 5. Americas Acute Respiratory Distress Syndrome Market: Historic and Forecast 5.1 Americas Acute Respiratory Distress Syndrome Market: Snapshot 5.2 Americas Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR) 5.3 Americas Acute Respiratory Distress Syndrome Market: Key Factors 5.4 Americas Acute Respiratory Distress Syndrome Market: Segment Analysis 5.5 Americas Acute Respiratory Distress Syndrome Market Segmentation: By End-User 5.5.1 Americas Acute Respiratory Distress Syndrome Market, By End-User Overview 5.5.2 Americas Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR) 5.5.3 Americas Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR) 5.5.4 Americas Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR) 5.5.5 Americas Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR) 5.5.6 Americas Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR) 5.6 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration 5.6.1 Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview 5.6.2 Americas Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 5.6.3 Americas Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR) 5.6.4 Americas Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR) 5.6.5 Americas Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 5.7 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode 5.7.1 Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview 5.7.2 Americas Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR) 5.7.3 Americas Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR) 5.8 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Country 5.8.1 Americas Acute Respiratory Distress Syndrome Market, by Country Overview 5.8.2 United States Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.2.1 United States Acute Respiratory Distress Syndrome Market, By End-User 5.8.2.2 United States Acute Respiratory Distress Syndrome Market, By Mode of Administration 5.8.2.3 United States Acute Respiratory Distress Syndrome Market, By Treatment Mode 5.8.3 Canada Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.3.1 Canada Acute Respiratory Distress Syndrome Market, By End-User 5.8.3.2 Canada Acute Respiratory Distress Syndrome Market, By Mode of Administration 5.8.3.3 Canada Acute Respiratory Distress Syndrome Market, By Treatment Mode 5.8.4 Brazil Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.4.1 Brazil Acute Respiratory Distress Syndrome Market, By End-User 5.8.4.2 Brazil Acute Respiratory Distress Syndrome Market, By Mode of Administration 5.8.4.3 Brazil Acute Respiratory Distress Syndrome Market, By Treatment Mode 5.8.5 Mexico Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.5.1 Mexico Acute Respiratory Distress Syndrome Market, By End-User 5.8.5.2 Mexico Acute Respiratory Distress Syndrome Market, By Mode of Administration 5.8.5.3 Mexico Acute Respiratory Distress Syndrome Market, By Treatment Mode 5.8.6 Rest of Americas Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.6.1 Rest of Americas Acute Respiratory Distress Syndrome Market, By End-User 5.8.6.2 Rest of Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration 5.8.6.3 Rest of Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode 6. Europe Acute Respiratory Distress Syndrome Market: Historic and Forecast 6.1 Europe Acute Respiratory Distress Syndrome Market: Snapshot 6.2 Europe Acute Respiratory Distress Syndrome Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR) 6.3 Europe Acute Respiratory Distress Syndrome Market: Key Factors 6.4 Europe Acute Respiratory Distress Syndrome Market: Segment Analysis 6.5 Europe Acute Respiratory Distress Syndrome Market Segmentation: By End-User 6.5.1 Europe Acute Respiratory Distress Syndrome Market, By End-User Overview 6.5.2 Europe Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR) 6.5.3 Europe Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR) 6.5.4 Europe Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR) 6.5.5 Europe Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR) 6.5.6 Europe Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR) 6.6 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration 6.6.1 Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview 6.6.2 Europe Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 6.6.3 Europe Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR) 6.6.4 Europe Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR) 6.6.5 Europe Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 6.7 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode 6.7.1 Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview 6.7.2 Europe Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR) 6.7.3 Europe Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR) 6.8 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Country 6.8.1 Europe Acute Respiratory Distress Syndrome Market, by Country Overview 6.8.2 Russia Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.2.1 Russia Acute Respiratory Distress Syndrome Market, By End-User 6.8.2.2 Russia Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.2.3 Russia Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.3 France Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.3.1 France Acute Respiratory Distress Syndrome Market, By End-User 6.8.3.2 France Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.3.3 France Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.4 United Kingdom Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.4.1 United Kingdom Acute Respiratory Distress Syndrome Market, By End-User 6.8.4.2 United Kingdom Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.4.3 United Kingdom Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.5 Germany Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.5.1 Germany Acute Respiratory Distress Syndrome Market, By End-User 6.8.5.2 Germany Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.5.3 Germany Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.6 Italy Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.6.1 Italy Acute Respiratory Distress Syndrome Market, By End-User 6.8.6.2 Italy Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.6.3 Italy Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.7 Spain Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.7.1 Spain Acute Respiratory Distress Syndrome Market, By End-User 6.8.7.2 Spain Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.7.3 Spain Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.8 Turkey Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.8.1 Turkey Acute Respiratory Distress Syndrome Market, By End-User 6.8.8.2 Turkey Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.8.3 Turkey Acute Respiratory Distress Syndrome Market, By Treatment Mode 6.8.9 Rest of Europe Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.9.1 Rest of Europe Acute Respiratory Distress Syndrome Market, By End-User 6.8.9.2 Rest of Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration 6.8.9.3 Rest of Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode 7. Asia Pacific Acute Respiratory Distress Syndrome Market: Historic and Forecast 7.1 Asia Pacific Acute Respiratory Distress Syndrome Market: Snapshot 7.2 Asia Pacific Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR) 7.3 Asia Pacific Acute Respiratory Distress Syndrome Market: Key Factors 7.4 Asia Pacific Acute Respiratory Distress Syndrome Market: Segment Analysis 7.5 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By End-User 7.5.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User Overview 7.5.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR) 7.5.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR) 7.5.4 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR) 7.5.5 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR) 7.5.6 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR) 7.6 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration 7.6.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview 7.6.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 7.6.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR) 7.6.4 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR) 7.6.5 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 7.7 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode 7.7.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview 7.7.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR) 7.7.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR) 7.8 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Country 7.8.1 Asia Pacific Acute Respiratory Distress Syndrome Market, by Country Overview 7.8.2 China Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.2.1 China Acute Respiratory Distress Syndrome Market, By End-User 7.8.2.2 China Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.2.3 China Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.3 India Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.3.1 India Acute Respiratory Distress Syndrome Market, By End-User 7.8.3.2 India Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.3.3 India Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.4 South Korea Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.4.1 South Korea Acute Respiratory Distress Syndrome Market, By End-User 7.8.4.2 South Korea Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.4.3 South Korea Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.5 Japan Korea Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.5.1 Japan Acute Respiratory Distress Syndrome Market, By End-User 7.8.5.2 Japan Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.5.3 Japan Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.6 Singapore Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.6.1 Singapore Acute Respiratory Distress Syndrome Market, By End-User 7.8.6.2 Singapore Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.6.3 Singapore Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.7 Indonesia Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.7.1 Indonesia Acute Respiratory Distress Syndrome Market, By End-User 7.8.7.2 Indonesia Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.7.3 Indonesia Acute Respiratory Distress Syndrome Market, By Treatment Mode 7.8.8 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.8.1 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User 7.8.8.2 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration 7.8.8.3 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode 8. Middle East & Africa Acute Respiratory Distress Syndrome Market: Historic and Forecast 8.1 Middle East & Africa Acute Respiratory Distress Syndrome Market: Snapshot 8.2 Middle East & Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR) 8.3 Middle East & Africa Acute Respiratory Distress Syndrome Market: Key Factors 8.4 Middle East and Africa Acute Respiratory Distress Syndrome Market: Segment Analysis 8.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By End-User 8.5.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By End-User Overview 8.5.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR) 8.5.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR) 8.5.4 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR) 8.5.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR) 8.5.6 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR) 8.6 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration 8.6.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview 8.6.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 8.6.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR) 8.6.4 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR) 8.6.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 8.7 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode 8.7.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview 8.7.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR) 8.7.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR) 8.8 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Country 8.8.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, by Country Overview 8.8.2 GCC Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 8.8.2.1 GCC Acute Respiratory Distress Syndrome Market, By End-User 8.8.2.2 GCC Acute Respiratory Distress Syndrome Market, By Mode of Administration 8.8.2.3 GCC Acute Respiratory Distress Syndrome Market, By Treatment Mode 8.8.3 Israel Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 8.8.3.1 Israel Acute Respiratory Distress Syndrome Market, By End-User 8.8.3.2 Israel Acute Respiratory Distress Syndrome Market, By Mode of Administration 8.8.3.3 Israel Acute Respiratory Distress Syndrome Market, By Treatment Mode 8.8.4 South Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 8.8.4.1 South Africa Acute Respiratory Distress Syndrome Market, By End-User 8.8.4.2 South Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration 8.8.4.3 South Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode 8.8.5 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 8.8.5.1 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By End-User 8.8.5.2 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration 8.8.5.3 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode 9. Market Dynamics 9.1 Impact assessment of Market Dynamics on Acute Respiratory Distress Syndrome Market 9.2 Drivers 9.3 Restraints 9.4 Trends 10. Ecosystem Analysis 10.1 Porter Analysis 11. Competitive Positioning 11.1 Companies' Competitive Positioning 11.2 Market Position Matrix 11.3 Market Share Analysis of Acute Respiratory Distress Syndrome Market 11.4 Company Profiles 11.4.1 United Therapeutics 11.4.2 Athersys 11.4.3 GE Healthcare 11.4.4 Apeptico Forschung 11.4.5 Fisher & Paykel Healthcare Limited 11.4.6 NRx Pharmaceuticals, Inc. 11.4.7 HEALIOS K.K 11.4.8 BioMarck Pharmaceuticals 11.4.9 Hamilton Company 11.4.10 Faron Pharmaceuticals 11.4.11 Other Leading Companies 12. About Us & Disclaimer
Publisher: Azoth Analytics
Related Reports
- Global Pediatric Oral Care Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product Type (Tooth Mousse, Toothpaste, Floss, Toothbrush and Other Product Types), Sales Channel, End-User, Region, By Country: 2020-2030
- Global Non-Drug Eluting Device Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Cardiovascular Diseases, Peripheral Artery Disease, Oncology, Urology and Other Applications), Material Type, End-User, Region, By Country: 2020-2030
- Global Medical Overmolding Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Surgical Instruments, Tubing Parts, Medical Cable, Needle Components and Other Applications), End-User Type, Overmold Material Type, Region, By Country: 2020-2030
- Global Medical Filters Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material Type (Polypropylene, Polyethersulfone (PES), Polytetrafluoroethylene (PTFE), Nylon and Other Material Types), Application, Usage Type, Region, By Country: 2020-2030
- Global Glass Ionomer Filling Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Defect Class (Class l & II, Class III, Class IV, Class V and Class VI), End-User Type, Product Type, Region, By Country: 2020-2030
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support